CHE logo

Chemed (CHE) Company Overview

Profile

Full Name:

Chemed Corporation

Sector:

Healthcare

Industry:

Medical Care Facilities

Country:

United States

IPO:

May 3, 1973

Indexes:

Not included

Website:

http://www.chemed.com

Description:

Chemed Corporation is an American company that provides medical and service services. Founded in 1947, the headquarters is located in Cincinnati, Ohio. Chemed Corporation has two subsidiaries: Vitas Healthcare Corporation (VITAS) and Roto-Rooter. VITAS offers hospice and palliative care services to patients across the United States, provided through a network of doctors, nurses, home care aides, social workers, and volunteers. Vitas Healthcare Corporation has approximately 8 hospice programs in 14 states and the District of Columbia. Roto-Rooter provides plumbing, sewer, and drain repair services, as well as water and sewer line cleaning services, and water damage restoration services throughout the United States and Canada.

Key Details

Price

$595.74

Market Cap

$8.72 B(Mid cap)

Last Dividend

$0.50

TTM Dividend Yield

0.32%

Annual Revenue

$2.43 B(+7.37% YoY)

Annual EPS

$19.89(+10.93% YoY)

PE Ratio

29.92

Annual ROE

27.12%

Annual Debt To Equity

0.00

Beta

0.33

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 24, 2025
Splits

Next split:

N/A

Recent split:

May 12, 2005

Analyst ratings

Recent major analysts updates

Nov 5, 24 RBC Capital
Outperform
May 21, 24 RBC Capital
Outperform
Mar 4, 24 RBC Capital
Outperform
Feb 29, 24 Oppenheimer
Outperform
Jan 17, 24 Oppenheimer
Outperform
Oct 30, 23 RBC Capital
Outperform
Jul 31, 23 RBC Capital
Outperform
Jul 27, 23 Oppenheimer
Outperform
May 1, 23 RBC Capital
Outperform
Apr 28, 23 Oppenheimer
Outperform

Screeners with CHE included

Mid cap stocks
US stocks
High Piotroski score stocks
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
Companies with growing dividends

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$595.74
CHE price is $595.74

Price All-time High

$650.42
CHE price is currently -8.41% below its historical high of $650.42

Price Analysts Target

$650.00
CHE price is currently -8.35% lower than the consensus analysts' forecast

Price Most Recent Change

+0.14%
CHE price was up +0.14% on Mar 7, 2025

Price YTD Change

+14.29%
CHE price is up +14.29% since January 1st

Price 3-Year Change

+23.24%
CHE price is up +23.24% over the past 3 years

Market cap

Market Cap

$8.72 B
CHE market capitalization is $8.72 billion

Market Cap 3-Year Change

+20.35%
CHE market capitalization is up +20.35% over the past 3 years

Market Cap All-time High

$9.83 B
CHE market capitalization is currently -11.32% below its historical high of $9.83 billion

Market Cap Sector Rank

91.52%
CHE market capitalization is higher than 91.52% of companies in Healthcare sector

Technical

Beta

0.33
CHE beta is 0.33

200-day SMA

$560.46
CHE price is currently +6.30% above its 200-day simple moving average

14-day RSI

65.33
CHE 14-day relative strength index is 65.33

30-day Relative Volume

1.20
CHE 30-day relative volume is 1.20

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.50
CHE last dividend was $0.50 per share, with an ex-dividend date of February 24, 2025

Next Dividend

-
CHE next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$1.80
CHE annual dividend per share is $1.80

Annual Dividend Per Share Sector Rank

67.06%
CHE annual dividend per share is higher than 67.06% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+15.38%
CHE annual dividend per share is up +15.38% year-on-year

Annual Dividend Per Share 3-Year Change

+28.57%
CHE annual dividend per share is up +28.57% over the past 3 years

Dividend yield

Annual Dividend Yield

0.30%
CHE annual dividend yield is 0.30%

Annual Dividend Yield Sector Rank

8.33%
CHE annual dividend yield is higher than 8.33% of companies in Healthcare sector

Other

Annual Payout Ratio

8.97%
CHE annual payout ratio is 8.97%

Annual Dividends Paid

$27.09 M
CHE annual dividends paid is $27.09 million

Annual FCF

$367.97 M
CHE annual free cash flow is $367.97 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$2.43 B
CHE annual revenue is $2.43 billion

Annual Revenue Analysts Estimate

$2.62 B
CHE annual revenue is currently -7.32% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+7.37%
CHE annual revenue is up +7.37% year-on-year

Annual Revenue Sector Rank

86.3%
CHE annual revenue is higher than 86.3% of companies in Healthcare sector

Profit

Annual Gross Profit

$854.35 M
CHE annual gross profit is $854.35 million

Annual Gross Margin

35.14%
CHE annual gross profit margin is 35.14%

Annual Operating Profit

$366.94 M
CHE annual operating income is $366.94 million

Annual Operating Margin

15.09%
CHE annual operating profit margin is 15.09%

Annual Net Income

$302.00 M
CHE annual net profit is $302.00 million

Annual Net Margin

12.42%
CHE annual net profit margin is 12.42%

EPS

Annual EPS

$19.89
CHE annual earnings per share is $19.89

Annual EPS Analysts Estimate

$25.17
CHE annual earnings per share is currently -20.98% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+10.93%
CHE annual earnings per share is up +10.93% year-on-year

Annual EPS Sector Rank

99.18%
CHE annual earnings per share is higher than 99.18% of companies in Healthcare sector

ROA & ROE

Annual ROA

18.10%
CHE annual return on assets is 18.10%

Annual ROE

27.12%
CHE annual return on equity is 27.12%

EBIT & EBITDA

Annual EBIT

$401.25 M
CHE annual earnings before interest & taxes is $401.25 million

Annual EBITDA

$464.29 M
CHE annual EBITDA is $464.29 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

29.92
CHE price to earnings ratio is 29.92

PE Ratio Sector Rank

57.64%
CHE price to earnings ratio is higher than 57.64% of companies in Healthcare sector

PB Ratio

PB Ratio

7.79
CHE price to book ratio is 7.79

PB Ratio Sector Rank

89.21%
CHE price to book ratio is higher than 89.21% of companies in Healthcare sector

PS Ratio

PS Ratio

3.59
CHE price to sales ratio is 3.59

PS Ratio Sector Rank

53.72%
CHE price to sales ratio is higher than 53.72% of companies in Healthcare sector

Enterprise value

Enterprise Value

$8.68 B
CHE enterprise value is $8.68 billion

Enterprise Value Sector Rank

90.46%
CHE enterprise value is higher than 90.46% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.70
CHE EV/EBITDA is 18.70

EV/EBITDA Sector Rank

89.93%
CHE EV/EBITDA is higher than 89.93% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.38
CHE annual current ratio is 1.38

Annual Quick Ratio

1.35
CHE annual quick ratio is 1.35

Leverage

Annual Debt To Equity

0.00
CHE annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

225.42
CHE annual interest coverage ratio is 225.42

Risk & Stability

Piotroski F-Score

6
CHE piotroski f-score is 6

Altman Z-Score

14.13
CHE altman z-score is 14.13

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.67 B
CHE annual total assets is $1.67 billion

Annual Non Current Assets

$1.27 B
CHE annual long term assets is $1.27 billion

Annual Current Assets

$394.75 M
CHE annual total current assets is $394.75 million

Annual Cash & Cash Equivalents

$178.35 M
CHE annual cash & cash equivalents is $178.35 million

Equity

Annual Book Value

$1.12 B
CHE annual book value is $1.12 billion

Annual Working Capital

$109.05 M
CHE annual working capital is $109.05 million

Liabilities

Annual Total Liabilities

$549.58 M
CHE annual total liabilities is $549.58 million

Annual Total Long Term Liabilities

$263.89 M
CHE annual total long term liabilities is $263.89 million

Annual Current Liabilities

$285.69 M
CHE annual total current liabilities is $285.69 million

Annual Accounts Payable

$44.15 M
CHE annual accounts payable is $44.15 million

Debt

Annual Total Debt

$140.84 M
CHE annual total debt is $140.84 million

Annual Total Debt 1-Year Change

+1.03%
CHE annual total debt is up +1.03% year-on-year

Annual Long Term Debt

$98.54 M
CHE annual long term debt is $98.54 million

Annual Short Term Debt

$42.31 M
CHE annual short term debt is $42.31 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$2.06 B
CHE annual total expenses is $2.06 billion

Annual Operating Expenses

$487.41 M
CHE annual total operating expenses is $487.41 million

Annual Cost Of Goods Sold

$1.58 B
CHE annual cost of goods sold is $1.58 billion

Annual SGA

$424.36 M
CHE annual SGA is $424.36 million

Annual D&A

$63.05 M
CHE annual depreciation & amortization is $63.05 million

Annual Interest Expense

$1.78 M
CHE annual interest expense is $1.78 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$417.50 M
CHE annual cash flow from operations is $417.50 million

Annual CFO 1-Year Change

+26.4%
CHE annual cash flow from operations is up +26.4% year-on-year

Annual CFI

-$143.91 M
CHE annual cash flow from investing activities is -$143.91 million

Annual CFI 1-Year Change

-137.31%
CHE annual cash flow from investing activities is down -137.31% year-on-year

Annual CFF

-$359.19 M
CHE annual cash flow from financing activities is -$359.19 million

Annual CFF 1-Year Change

-349.98%
CHE annual cash flow from financing activities is down -349.98% year-on-year

Free CashFlow

Annual FCF

$367.97 M
CHE annual free cash flow is $367.97 million

Annual FCF 1-Year Change

+34.57%
CHE annual free cash flow is up +34.57% year-on-year

CAPEX

Annual CAPEX

$49.53 M
CHE annual capital expenditures is $49.53 million

Annual CAPEX 1-Year Change

-12.88%
CHE annual capital expenditures is down -12.88% year-on-year

Institutional Ownership

Similar stocks

HQY logo
HealthEquity (HQY)
ASND logo
Ascendis Pharma A/S (ASND)
RGEN logo
Repligen (RGEN)
QGEN logo
Qiagen NV (QGEN)
EXAS logo
Exact Sciences (EXAS)
JAZZ logo
Jazz Pharmaceuticals (JAZZ)
CRL logo
Charles River Laboratories International (CRL)
TEM logo
Tempus AI (TEM)
PCVX logo
Vaxcyte (PCVX)

FAQ

  • What is the ticker symbol for Chemed?
  • Does Chemed pay dividends?
  • What sector is Chemed in?
  • What industry is Chemed in?
  • What country is Chemed based in?
  • When did Chemed go public?
  • Is Chemed in the S&P 500?
  • Is Chemed in the NASDAQ 100?
  • Is Chemed in the Dow Jones?
  • When was Chemed's last earnings report?
  • When does Chemed report earnings?
  • Should I buy Chemed stock now?

What is the ticker symbol for Chemed?

The ticker symbol for Chemed is NYSE:CHE

Does Chemed pay dividends?

Yes, Chemed pays dividends. The last payment was $0.50, with an ex-dividend date on February 24, 2025

What sector is Chemed in?

Chemed is in the Healthcare sector

What industry is Chemed in?

Chemed is in the Medical Care Facilities industry

What country is Chemed based in?

Chemed is headquartered in United States

When did Chemed go public?

Chemed's initial public offering (IPO) was on May 3, 1973

Is Chemed in the S&P 500?

No, Chemed is not included in the S&P 500 index

Is Chemed in the NASDAQ 100?

No, Chemed is not included in the NASDAQ 100 index

Is Chemed in the Dow Jones?

No, Chemed is not included in the Dow Jones index

When was Chemed's last earnings report?

Chemed's most recent earnings report was on Feb 26, 2025

When does Chemed report earnings?

The next expected earnings date for Chemed is Apr 24, 2025

Should I buy Chemed stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions